Ad
related to: denali therapeutics stockinvesco.com has been visited by 100K+ users in the past month
Search results
Denali Therapeutics Inc. (DNLI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 1 year agoDenali Therapeutics Inc. (DNLI) possesses the right combination of the two key ingredients for a...
Denali Therapeutics Inc. (DNLI) Reports Q3 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 years agoDenali Therapeutics Inc. (DNLI) delivered earnings and revenue surprises of -1.20% and 64.61%,...
Denali Therapeutics Inc. (DNLI) Moves 17.7% Higher: Will This Strength Last?
Zacks via Yahoo Finance· 2 years agoDenali Therapeutics Inc. (DNLI) saw its shares surge in the last session with trading volume being...
Why Is Denali Therapeutics Inc. (DNLI) Down 5.2% Since Last Earnings Report?
Zacks via Yahoo Finance· 6 months agoIt has been about a month since the last earnings report for Denali Therapeutics Inc. (DNLI). Shares...
In the wake of Denali Therapeutics Inc.'s (NASDAQ:DNLI) latest US$402m market cap drop,...
Simply Wall St. via Yahoo Finance· 11 months agoKey Insights Given the large stake in the stock by institutions, Denali Therapeutics' stock price...
Is There An Opportunity With Denali Therapeutics Inc.'s (NASDAQ:DNLI) 50% Undervaluation?
Simply Wall St. via Yahoo Finance· 1 month agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Denali Therapeutics fair value estimate is...
After losing 39% in the past year, Denali Therapeutics Inc. (NASDAQ:DNLI) institutional owners must...
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights Given the large stake in the stock by institutions, Denali Therapeutics' stock price...
Wall Street Analysts Think Denali Therapeutics Inc. (DNLI) Could Surge 121.53%: Read This Before...
Zacks via Yahoo Finance· 7 months agoThe average of price targets set by Wall Street analysts indicates a potential upside of 121.5% in...
Pinning Down Denali Therapeutics Inc.'s (NASDAQ:DNLI) P/S Is Difficult Right Now
Simply Wall St. via Yahoo Finance· 10 months agoThere wouldn't be many who think Denali Therapeutics Inc.'s (NASDAQ:DNLI) price-to-sales (or "P/S")...
